Cue Biopharma Inc organizacji ROCE
Jaka jest wartość ROCE organizacji Cue Biopharma Inc?
Wartość ROCE organizacji Cue Biopharma Inc to -176.68%
Jaka jest definicja ROCE?
Zwrot z zaangażowanego kapitału Return on capital employed (ROCE) to wskaźnik finansowy, który mierzy zyskowność przedsiębiorstwa i efektywność, z jaką wykorzystywany jest jego kapitał.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE firm w Health Care sektor na NASDAQ w porównaniu do Cue Biopharma Inc
Czym się zajmuję organizacja Cue Biopharma Inc?
cue biopharma is an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. we design biologics to engage and modulate the activity of disease-associated t cells in the patient’s body, offering significant therapeutic advantages while potentially minimizing or eliminating unwanted side effects. we believe our biologics allow us to target antigen-specific t cell populations in a variety of indications using a simple peptide exchange within previously-validated drug frameworks developed from the cue biologics platform. this flexibility could truncate the drug selection and development process, moving effective therapeutics from discovery to clinical validation more rapidly and cost efficiently than current industry standard timelines and costs. headquartered in kendall square, cambridge, ma, we are led by an experienced management team and sci
Firmy z roce podobne do Cue Biopharma Inc
- Wartość ROCE organizacji Aqua Bio Technology ASA to -179.27%
- Wartość ROCE organizacji Infield Minerals to -179.20%
- Wartość ROCE organizacji Openpay Ltd to -178.61%
- Wartość ROCE organizacji Lixte Biotechnology to -178.60%
- Wartość ROCE organizacji Vincera Pharma to -178.46%
- Wartość ROCE organizacji Allakos Inc to -178.25%
- Wartość ROCE organizacji Cue Biopharma Inc to -176.68%
- Wartość ROCE organizacji ProShares Managed Futures Strategy to -176.67%
- Wartość ROCE organizacji Mimedia Inc to -176.40%
- Wartość ROCE organizacji Surface Oncology Inc to -176.37%
- Wartość ROCE organizacji Fluent Inc to -176.35%
- Wartość ROCE organizacji UrbanGold Minerals to -176.34%
- Wartość ROCE organizacji Elys Game Technology to -176.22%